ARCHIVES

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986

Funding Opportunities: Lymphoma Fellowship

June 8, 2001

NCI-Approved CTEP Trials For the Month of November

November 30, 2012

Nixon Resignation Won’t Hurt Cancer Program, Might Lead To More Money; Weinberger Stays

August 16, 1974

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007